Status:
COMPLETED
The Value of Tranxemic Acid to Reduce Intraoperative Blood Loss During Elective Cesarean Sections in High Risk Women
Lead Sponsor:
Cairo University
Conditions:
Intraoperative Bleeding
Eligibility:
FEMALE
18-45 years
Phase:
NA
Brief Summary
A full medical history will be obtained from all participants. Obstetric ultrasonography and laboratory tests will be performed.According to group assignment, either 1 g(10 mL) tranexamic acid stored ...
Detailed Description
A full medical history will be obtained from all participants. Obstetric ultrasonography and laboratory tests will be performed, including prothrombin time, prothrombin concentration, complete blood c...
Eligibility Criteria
Inclusion
- • Grand multipara
- Multiple pregnancy
- Polyhydraminos (AFI is more than 24 cm).
- Placenta previa
- Gestational diabetes mellitus
- Preeclampsia
- Anemia complicating pregnancy (Hemoglobin is less than 11 gm/dl)
Exclusion
- • Allergy to tranxemic acid.
- H/o suggestive of bleeding disorders
- previous history of deep vein thrombosis
- Abnormally invasive placenta
- Emergency cesarean sections
- Intraoprative complications during cesarean sections as uterine artery injury and broad ligamentary hematoma.
Key Trial Info
Start Date :
January 31 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 2 2020
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT03820206
Start Date
January 31 2019
End Date
January 2 2020
Last Update
January 6 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kasr Alainy medical school
Cairo, Egypt, 12151